We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALU icon
2876
Kaiser Aluminum
KALU
$2.57B
$377K ﹤0.01%
3,995
-43,864
-92% -$4.23M
OTMOW
2877
CALL
DELISTED
Otonomo Technologies Ltd. Warrant
OTMOW
$377K ﹤0.01%
191,361
-8,639
-4% -$2.04K
APMIW
2878
CALL
DELISTED
AxonPrime Infrastructure Acquisition Corporation Warrants
APMIW
$376K ﹤0.01%
39,015
VERU icon
2879
Veru
VERU
$35.2M
$375K ﹤0.01%
+7,758
New +$421K
AVCT
2880
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$375K ﹤0.01%
26,586
+18,500
+229% +$337K
PAWZ icon
2881
ProShares Pet Care ETF
PAWZ
$34.5M
$374K ﹤0.01%
+5,628
New +$377K
WEL.WS
2882
CALL
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$374K ﹤0.01%
+37,499
New +$13.4K
CRXTW
2883
CALL
DELISTED
Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
$373K ﹤0.01%
250,000
ACNT icon
2884
Ascent Industries
ACNT
$139M
$371K ﹤0.01%
23,144
+9,503
+70% +$163K
WIT icon
2885
Wipro
WIT
$19.3B
$371K ﹤0.01%
+96,324
New +$380K
PPH icon
2886
VanEck Pharmaceutical ETF
PPH
$989M
$370K ﹤0.01%
+4,640
New +$355K
PRIM icon
2887
Primoris Services
PRIM
$4.14B
$367K ﹤0.01%
+15,374
New +$396K
STOK icon
2888
Stoke Therapeutics
STOK
$1.83B
$362K ﹤0.01%
17,237
-25,164
-59% -$504K
FLL icon
2889
Full House Resorts
FLL
$83.8M
$361K ﹤0.01%
37,567
TGS icon
2890
Transportadora de Gas del Sur
TGS
$4.49B
$361K ﹤0.01%
51,540
-81,931
-61% -$437K
SIEN
2891
DELISTED
Sientra, Inc.
SIEN
$360K ﹤0.01%
16,230
+3,710
+30% +$102K
CTO
2892
CTO Realty Growth
CTO
$750M
$359K ﹤0.01%
+16,233
New +$335K
INFI
2893
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$359K ﹤0.01%
316,146
-284,093
-47% -$339K
ALRS icon
2894
Alerus Financial
ALRS
$834M
$357K ﹤0.01%
12,918
-230
-2% -$6.64K
CLOU icon
2895
Global X Cloud Computing ETF
CLOU
$234M
$357K ﹤0.01%
16,200
+3,835
+31% +$84.6K
GRBK icon
2896
Green Brick Partners
GRBK
$3.16B
$356K ﹤0.01%
+18,006
New +$416K
SYRE icon
2897
Spyre Therapeutics
SYRE
$8.42B
$355K ﹤0.01%
6,167
+4,502
+270% +$378K
TDS icon
2898
Telephone and Data Systems
TDS
$3.84B
$355K ﹤0.01%
18,772
-27,229
-59% -$527K
WSC icon
2899
WillScot Mobile Mini Holdings
WSC
$4.37B
$353K ﹤0.01%
9,009
-8,148
-47% -$306K
HAFC icon
2900
Hanmi Financial
HAFC
$942M
$352K ﹤0.01%
+14,296
New +$369K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.